Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT

Donal P McLornan; Luuk Gras; Ivonne Martin; Tiarlan Sirait; Thomas Schroeder; Igor Wolfgang Blau; Jürgen Kuball; Jenny Byrne; Matthew Collin; Michael Stadler; Déborah Desmier; Urpu Salmenniemi; Pavel Jindra; Natalia Mikhailova; Stig Lenhoff; Jose Rifón; Marie Robin; Montserrat Rovira; Hendrik Veelken; Alicja Sadowska-Klasa; Marco Zecca; Patrick J Hayden; Tomasz Czerw; Juan Carlos Hernández-Boluda; Ibrahim Yakoub-Agha

doi:10.1111/bjh.18219

Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT

Br J Haematol. 2022 Jul;198(1):209-213. doi: 10.1111/bjh.18219. Epub 2022 Apr 28.

Authors

Donal P McLornan¹, Luuk Gras², Ivonne Martin², Tiarlan Sirait³, Thomas Schroeder⁴, Igor Wolfgang Blau⁵, Jürgen Kuball⁶, Jenny Byrne⁷, Matthew Collin⁸, Michael Stadler⁹, Déborah Desmier¹⁰, Urpu Salmenniemi¹¹, Pavel Jindra¹², Natalia Mikhailova¹³, Stig Lenhoff¹⁴, Jose Rifón¹⁵, Marie Robin¹⁶, Montserrat Rovira¹⁷, Hendrik Veelken¹⁸, Alicja Sadowska-Klasa¹⁹, Marco Zecca²⁰, Patrick J Hayden²¹, Tomasz Czerw²², Juan Carlos Hernández-Boluda²³, Ibrahim Yakoub-Agha²⁴

Affiliations

¹ Department of Stem Cell Transplantation and Haematology, University College London Hospitals, London, UK.
² EBMT Statistical Unit, Leiden, The Netherlands.
³ EBMT Leiden Study Unit, Leiden, The Netherlands.
⁴ Department of Haematology and Stem Cell Transplantation, University Hospital, Essen, Germany.
⁵ Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany.
⁶ University Medical Centre, Utrecht, The Netherlands.
⁷ Department of Haematology, Nottingham University Hospital, Nottingham, UK.
⁸ Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
⁹ Hannover Medical School, Hannover, Germany.
¹⁰ Department of Stem Cell Transplant, Hopital La Miletrie, Poitiers, France.
¹¹ HUCH Comprehensive Cancer Center, Helsinki, Finland.
¹² Department of Haematology&Oncology, Charles University Hospital, Pilsen, Czech Republic.
¹³ RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia.
¹⁴ Skanes University Hospital, Lund, Sweden.
¹⁵ Clínica Universitaria de Navarra, Pamplona, Spain.
¹⁶ Hôpital Saint-Louis, APHP, Université de Paris, Paris, France.
¹⁷ Bone Marrow Transplant Unit, Haematology Department, ICHMO, Hospital Clinic, IDIBAPS, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
¹⁸ Leiden University Hospital, Leiden, The Netherlands.
¹⁹ Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland.
²⁰ Paediatric Haematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
²¹ Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
²² Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
²³ Department of Hematology, Hospital Clínico Universitario, Valencia, Spain.
²⁴ CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France.

PMID: 35482558
DOI: 10.1111/bjh.18219

No abstract available

Keywords: allogeneic stem cell transplant; chronic eosinophilic leukaemia; conditioning; hypereosinophilic syndrome; non-relapse mortality.

Publication types

Letter

MeSH terms

Graft vs Host Disease* / etiology
Hematopoietic Stem Cell Transplantation*
Humans
Neoplasms*
Retrospective Studies
Transplantation Conditioning